Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Tax Provisions (2016 - 2018)

Historic Tax Provisions for China Pharma Holdings (CPHI) over the last 10 years, with Q4 2018 value amounting to -$66498.0.

  • China Pharma Holdings' Tax Provisions fell 31784.77% to -$66498.0 in Q4 2018 from the same period last year, while for Dec 2018 it was -$178408.0, marking a year-over-year decrease of 24548.36%. This contributed to the annual value of -$178408.0 for FY2018, which is 24548.36% down from last year.
  • China Pharma Holdings' Tax Provisions amounted to -$66498.0 in Q4 2018, which was down 31784.77% from -$160485.0 recorded in Q3 2018.
  • China Pharma Holdings' Tax Provisions' 5-year high stood at $243131.0 during Q4 2016, with a 5-year trough of -$160485.0 in Q3 2018.
  • In the last 5 years, China Pharma Holdings' Tax Provisions had a median value of -$2821.0 in 2015 and averaged $4846.8.
  • In the last 5 years, China Pharma Holdings' Tax Provisions skyrocketed by 871861.04% in 2016 and then tumbled by 61440.8% in 2018.
  • Quarter analysis of 5 years shows China Pharma Holdings' Tax Provisions stood at -$19284.0 in 2014, then skyrocketed by 85.37% to -$2821.0 in 2015, then surged by 8718.61% to $243131.0 in 2016, then tumbled by 87.45% to $30525.0 in 2017, then plummeted by 317.85% to -$66498.0 in 2018.
  • Its last three reported values are -$66498.0 in Q4 2018, -$160485.0 for Q3 2018, and $22590.0 during Q2 2018.